ACS BIOT 2016: San Diego
BIOT 405: More affordable version of therapeutic protein recombinant Streptokinase to address over a million ST elevated Micardial Infraction (STEMI) deaths in part of the world where affordability is the key. Cardiovascular diseases (CVD) have been leading cause of morbidity and mortality in Indian subcontinent and Myocardial Infraction is one of the major reason for […]




